Show simple item record

dc.contributor.authorKavanagh, Matthew
dc.contributor.authorCohn, Jennifer
dc.contributor.authorMabote, Lynette
dc.contributor.authorMeier, Benjamin Mason
dc.contributor.authorWilliams, Brian
dc.contributor.authorRussell, Asia
dc.contributor.authorSikwese, Kenly
dc.contributor.authorBaker, Brook
dc.date.accessioned2015-07-30T14:30:22Z
dc.date.available2015-07-30T14:30:22Z
dc.date.issued2015-06-11
dc.identifier.citationEvolving Human Rights and the Science of Antiretroviral Medicine. 2015, 17 (1):E76-90 Health Hum Rightsen_GB
dc.identifier.issn2150-4113
dc.identifier.pmid26204587
dc.identifier.urihttp://hdl.handle.net/10144/561280
dc.description.abstractRecent years have seen significant advances in the science of using antiretroviral medicines (ARVs) to fight HIV. Where not long ago ARVs were used late in disease to prevent sick people from dying, today people living with HIV can use ARVs to achieve viral suppression early in the course of disease. This article reviews the mounting new scientific evidence of major clinical and prevention ARV benefits. This has changed the logic of the AIDS response, eliminating competition between "treatment" and "prevention" and encouraging early initiation of treatment for individual and public health benefit. These breakthroughs have implications for the health-related human rights duties of States. With medical advance, the "highest attainable standard" of health has taken a leap, and with it the rights obligations of States. We argue that access to early treatment for all is now a core State obligation and restricting access to, or failing to provide accurate information about, it violates both individual and collective rights. In a context of real political and technical challenges, however, in this article we review the policy implications of evolving human rights obligations given the new science. National and international legal standards require action on budget, health and intellectual property policy, which we outline.
dc.language.isoenen
dc.publisherHarvard University Pressen_GB
dc.rightsArchived with thanks to Health and Human Rights Journal's open accessen_GB
dc.titleEvolving Human Rights and the Science of Antiretroviral Medicineen
dc.identifier.journalHealth and Human Rightsen_GB
refterms.dateFOA2019-03-04T12:31:42Z
html.description.abstractRecent years have seen significant advances in the science of using antiretroviral medicines (ARVs) to fight HIV. Where not long ago ARVs were used late in disease to prevent sick people from dying, today people living with HIV can use ARVs to achieve viral suppression early in the course of disease. This article reviews the mounting new scientific evidence of major clinical and prevention ARV benefits. This has changed the logic of the AIDS response, eliminating competition between "treatment" and "prevention" and encouraging early initiation of treatment for individual and public health benefit. These breakthroughs have implications for the health-related human rights duties of States. With medical advance, the "highest attainable standard" of health has taken a leap, and with it the rights obligations of States. We argue that access to early treatment for all is now a core State obligation and restricting access to, or failing to provide accurate information about, it violates both individual and collective rights. In a context of real political and technical challenges, however, in this article we review the policy implications of evolving human rights obligations given the new science. National and international legal standards require action on budget, health and intellectual property policy, which we outline.


Files in this item

Thumbnail
Name:
Kavanagh M et al - Evolving Human ...
Size:
226.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record